Protease inhibitor
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- MORINAGA MILK IND CO LTD
- Publication Date
- 2005-11-02
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to a cysteine protease inhibitor, which comprises one or more components selected from lactoferrin, a peptide fragment of lactoferrin or transferrin as an active ingredient, which can be used to treat A preventive or therapeutic agent for diseases such as osteoporosis and malignant hypercalcemia, and can be used in food, beverage, feed and the like. Background technique
[0002] Proteolytic enzymes having a sulfhydryl group in their active center are generally referred to as cysteine proteases (thiol proteases). Cathepsin L, cathepsin B or cathepsin K, together with calcium-dependent neutral protease (CAMP), papain, ficin and Promelain, is one of the typical cysteine proteases. Substances that are expected to have an inhibitory effect on these cysteine proteases can be used as therapeutic agents for diseases related to cysteine proteases, including the following diseases: muscular dystrophy, dysplasia, myocardia...